Cleared Special

K200107 - epoc Blood Analysis System (FDA 510(k) Clearance)

Jun 2020
Decision
140d
Days
Class 2
Risk

K200107 is an FDA 510(k) clearance for the epoc Blood Analysis System. This device is classified as a Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph (Class II - Special Controls, product code CHL).

Submitted by Epocal, Inc. (Ottawa, CA). The FDA issued a Cleared decision on June 5, 2020, 140 days after receiving the submission on January 17, 2020.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1120.

Submission Details

510(k) Number K200107 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 17, 2020
Decision Date June 05, 2020
Days to Decision 140 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code CHL - Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1120